Dyadic International Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Dyadic International, Inc., a Delaware corporation, on January 29, 2007. The report discloses actions taken by the Compensation Committee of the Board of Directors regarding executive compensation for services rendered during calendar year 2006.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to specific executive bonus awards:
- Wayne Moor (CFO and VP): $35,000 cash bonus.
- Ratnesh (Ray) Chandra (SVP, Marketing--Biotechnology Systems): $9,000 cash bonus.
- Kent M. Sproat (EVP, Enzyme Business): $20,000 cash bonus.
- Alexander (Sasha) Bondar (VP, Strategy & Corporate Development): $15,000 cash bonus.
- Mark A. Emalfarb (CEO): $75,000 cash bonus for 2006 (payment deferred); $150,000 in previously accrued bonuses for 2004 and 2005 approved for payment.
Material Changes
The filing reports the approval of cash bonuses for named executive officers for 2006. A material change involves the CEO's compensation structure: the 2006 bonus was deferred pending future Board discretion, while previously accrued bonuses from 2004 and 2005 were approved for immediate payment.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, market outlook, or discussion of risks and contingencies. The primary unusual item is the deferral of the CEO's 2006 bonus payment, which is contingent on the Committee deeming it advisable to make such payment.
Investor Verification Points
- Verify the total cash outflow impact of the approved bonuses, including the $150,000 in previously accrued amounts for the CEO.
- Confirm the conditions or timeline for the payment of the CEO's deferred $75,000 bonus.
- Review the definitive 2006 proxy statement to cross-reference the named executive officers and their base compensation.